Onconic Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	865,328	176,537	-	-	-
Enterprise Value	811,914	152,373	-	-	-
Last Close Price	19450.00	4085.00	-	-	-
PS Ratio	18.55	11.90	-	-	-
PB Ratio	12.56	3.15	-	-	-
P/TBV Ratio	12.56	3.15	-	-	-
EV/Sales Ratio	17.40	10.27	-	-	-
Debt / Equity Ratio	0.00	0.01	-0.06	0.00	-0.02
Debt / EBITDA Ratio	0.01	-	0.13	-	-
Debt / FCF Ratio	0.02	-	0.12	-	-
Asset Turnover	0.87	0.30	0.62	0.00	-
Quick Ratio	12.64	10.61	0.71	1.06	36.08
Current Ratio	13.21	10.94	0.71	1.06	36.10
Return on Equity (ROE)	33.75%	-32.29%	-	-	-
Return on Assets (ROA)	14.36%	-6.09%	4.07%	-36.85%	-
Return on Invested Capital (ROIC)	15.50%	-11.81%	-	-	-
Return on Capital Employed (ROCE)	18.00%	-8.50%	-39.40%	-343.70%	-44.10%
Earnings Yield	1.94%	-4.58%	-	-	-
FCF Yield	0.82%	-4.52%	-	-	-
Buyback Yield / Dilution	-	-41.46%	0.00%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.